MILLENNIUM MANAGEMENT LLC
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,018,183
+$2,109,459 QoQ
Shares Held
1,289,822
+91.6% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Derivatives in ZNTL
reported options exposure · as of Sep 30, 2023CallValue
$1,905,700
CallShares
95,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ZNTL ranks #216 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ZNTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,018,183 | 1,289,822 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $908,724 | 673,129 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,362,806 | 902,521 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,033,097 | 3,476,808 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,880,527 | 3,069,514 | Shares | Sole | 2025-05-15 | |
| 2025-01-29 | $7,146,653 | 3,781,298 | Shares | Sole | 2025-02-04 | |
| 2024-12-31 | $2,901,415 | 957,563 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,260,796 | 886,086 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,605,766 | 392,608 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,882,034 | 246,322 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $465,029 | 30,695 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,905,700 | 95,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $8,965,215 | 446,920 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,312,507 | 188,320 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $1,390,753 | 49,300 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $505,576 | 29,394 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $648,226 | 32,186 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,180,555 | 100,672 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $1,384,200 | 30,000 | Put | Sole | 2022-05-16 | |
| 2021-12-31 | $3,023,301 | 35,966 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $1,260,900 | 15,000 | Call | Sole | 2022-02-14 | |
| 2021-06-30 | $1,402,777 | 26,368 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,563,856 | 128,229 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||